GLP-1 Drugs: Lower Dementia Risk, But What Are the Side Effects
Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications primarily used to manage type 2 diabetes and assist in weight loss, have recently gained attention […]
Skip to content
You May Also Like:
Infectious Disease Breakthroughs: Shaping the Future of Patient Care
Advancing Infectious Disease Care Through Innovation and Evidence Infectious diseases remain one of the most pressing challenges in global healthcare, and new research is reshaping […]
Critical Care Advances: Rethinking ICU Practices for Better Outcomes
Transforming Critical Care Through Evidence-Based Practices Critical care medicine is undergoing a significant transformation as new research challenges long-standing practices in intensive care units. Recent […]
Bystro AI: The Future of Personalized Healthcare Beyond ChatGPT
How Bystro AI is Redefining the Future of Health Artificial intelligence has already begun reshaping healthcare, but Bystro AI is taking it a step further. […]
Rethinking Global Health Reform: Building a Fairer Future
The Urgent Need for a Decentralised Global Health System The Wellcome report, From Rethinking to Reform: The Way Forward for the Global Health System, draws […]
Pakistan Dismisses Taliban’s False Claim on Kabul Strike
Pakistan’s Response to Taliban’s Baseless Allegations Pakistan has categorically denied the Taliban’s accusation that it targeted a drug rehabilitation hospital in Kabul. Federal Minister for […]
Pakistan Maintains Three-Month Medicine Stock Amid Middle East Tensions
Pakistan’s Healthcare System Shows Resilience in Face of Supply Chain Challenges The Drug Regulatory Authority of Pakistan (DRAP) has confirmed that the country currently holds […]